Product How it works Pricing Blog FAQ About Contact
Ramsay Générale de Santé

Ramsay Générale de Santé (EPA: GDS) net income

Ramsay Générale de Santé reported a net loss of €48.3m for fiscal 2025; in fiscal 2024 it reported a net loss of €54.1m. Earnings per share were −€0.44.

Net income, in millions of euros65.02020118.4202149.42022-53.92023-54.12024-48.32025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025−€48.3m—−0.9%−€0.44
2024−€54.1m—−1.0%−€0.49
2023−€53.9m−209.1%−1.1%−€0.49
2022€49.4m−58.3%1.1%€0.45
2021€118.4m+82.2%2.8%€1.07
2020€65.0m—1.6%€0.59

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of euros, except per-share amounts.

Questions about the net income of Ramsay Générale de Santé

How much did Ramsay Générale de Santé earn in fiscal 2025?
Ramsay Générale de Santé reported a net loss of €48.3m for fiscal 2025. In fiscal 2024 it reported a net loss of €54.1m.
What are the earnings per share of Ramsay Générale de Santé?
They were −€0.44 in fiscal 2025, compared with −€0.49 in fiscal 2024.
What was the most profitable year for Ramsay Générale de Santé?
Of its last 6 fiscal years, fiscal 2021, with €118.4m.
Where do the figures for Ramsay Générale de Santé come from?
From the report Ramsay Générale de Santé files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.

Where each figure comes from

From the annual report Ramsay Générale de Santé files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Ramsay Générale de Santé: the Ramsay Générale de Santé page · annual accounts · revenue.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.